According to the results of recently conducted large randomized clinical trials, the proportion of clinically insignificant prostate cancer diagnosed by PSA screening was high, and as a result, several unnecessary TRUS-guided prostate biopsy were performed25. The gene discussed is KLK3; the disease is prostate carcinoma.